Under the supply agreement, SkyPeople is expected to supply Boai with 150metric tons of Turnjujube concentrate valued at approximately $2.2m in aggregate for use in the production of select Chinese medicines manufactured by Boai Pharmaceuticals.
SkyPeople said that, Turnjujube is rich in glucose and potassium malate, which is sweetened during the processing of Turjujube concentrate. When used as medicine, the concentrate serves as a diuretic beneficial in the delivery of well-known traditional Chinese medicines and particularly those needed for liver function and rejuvenation.
SkyPeople plans to produce Turnjujube concentrate on the company’s concentrate production facility in the Jingyang factory, where the SkyPeople produces its pear juice products. SkyPeople is expected to produce Turnjujube concentrate from April through July of each year.
Yongke Xue, chairman and CEO of Sky People Fruit Juice, said: “We consider ourselves the specialty fruit juice producer in China. Specialty concentrates have potential to fill gaps during our traditional harvest and concentrate manufacturing seasons.
“As the company with a Provincial-Level Corporate Technology Center in the food industry in Shaanxi Province, the introduction of this new product not only demonstrates SkyPeople’s R&D capacity, but is also a considerable step forward in our exploration of specialty concentrates for uses in other market segments, such as pharmaceutical industry.
“We look forward to developing other specialty customers like Boai pharmaceuticals in the future and generating additional revenues for SkyPeople as we sign new supplier agreements with other customers.”